Nepsone is a preclinical-stage pharmaceutical company developing drugs to treat dermatological conditions that arise due to an imbalance in the autonomic nervous system. Currently, these conditions are believed to originate in the immune system. Nepsone foundational neuroimmunology theory on the origin of psoriasis teaches us that an imbalance in neuropeptide activity in the body leads to these conditions. Our drugs are designed to utilize the body’s natural mechanisms to bring back balance and alleviate the disease.
| Website | https://nepsone.com |
| Revenue | $2 million |
| Employees | 7 (4 on RocketReach) |
| Founded | 2004 |
| Address | 77 Laugavegur, Reykjavik 101, IS |
| Phone | +354 555 1634 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical, Dermatology, Drug Development, Preclinical, Autonomic Nervous System, Immune System, Skin Conditions, Therapeutics, Biopharma, Clinical Trials, Research, Healthcare, New Drugs, Medical, Pharma, Innovation, Technology, Science |
| Competitors | Cumulus Imaging, Inc., Cloudrexx AG, Paragon Cloud, Inc., RevPart, Nuvolo, Dataverse Inc., Predictive Solutions, ClearSky Data, Nimbus Tech Consulting, Apex Data Solutions, LLC +5 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Nepsone ehf employee's phone or email?
The Nepsone ehf annual revenue was $2 million in 2026.
Stefan Sveinsson is the CEO of Nepsone ehf.
4 people are employed at Nepsone ehf.
The NAICS codes for Nepsone ehf are [325, 32, 3254, 32541].
The SIC codes for Nepsone ehf are [283, 28].